# Snap Inc: financial statements, quarterly SNAP · NYSE · CIK 1564408 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/snap.md) · [Financials](/companies/snap/financials.md) · [Filings](/companies/snap/filings.md) · [Insiders](/companies/snap/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/snap/financials.md?period=annual). ## Income statement | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [1,189](/filings/0001564408-24-000062.md) | [1,361 d](/filings/0001564408-26-000013.md) | [1,195](/filings/0001564408-25-000030.md) | [1,237](/filings/0001564408-25-000052.md) | [1,373](/filings/0001564408-25-000065.md) | [1,557 d](/filings/0001564408-26-000013.md) | [1,363](/filings/0001564408-26-000027.md) | [1,345](/filings/0001564408-26-000052.md) | [1,507](/filings/0001564408-25-000065.md) | [1,716 d](/filings/0001564408-26-000013.md) | [1,529](/filings/0001564408-26-000027.md) | [1,599](/filings/0001564408-26-000052.md) | | Cost of revenue | $m | [556](/filings/0001564408-24-000062.md) | [622 d](/filings/0001564408-26-000013.md) | [575](/filings/0001564408-25-000030.md) | [589](/filings/0001564408-25-000052.md) | [639](/filings/0001564408-25-000065.md) | [672 d](/filings/0001564408-26-000013.md) | [640](/filings/0001564408-26-000027.md) | [653](/filings/0001564408-26-000052.md) | [674](/filings/0001564408-25-000065.md) | [702 d](/filings/0001564408-26-000013.md) | [665](/filings/0001564408-26-000027.md) | [668](/filings/0001564408-26-000052.md) | | Research and development | $m | [495](/filings/0001564408-24-000062.md) | [484 d](/filings/0001564408-26-000013.md) | [450](/filings/0001564408-25-000030.md) | [406](/filings/0001564408-25-000052.md) | [413](/filings/0001564408-25-000065.md) | [423 d](/filings/0001564408-26-000013.md) | [424](/filings/0001564408-26-000027.md) | [443](/filings/0001564408-26-000052.md) | [453](/filings/0001564408-25-000065.md) | [473 d](/filings/0001564408-26-000013.md) | [478](/filings/0001564408-26-000027.md) | [542](/filings/0001564408-26-000052.md) | | Operating income | $m | [(380)](/filings/0001564408-24-000062.md) | [(249) d](/filings/0001564408-26-000013.md) | [(333)](/filings/0001564408-25-000030.md) | [(254)](/filings/0001564408-25-000052.md) | [(173)](/filings/0001564408-25-000065.md) | [(26.9) d](/filings/0001564408-26-000013.md) | [(194)](/filings/0001564408-26-000027.md) | [(260)](/filings/0001564408-26-000052.md) | [(128)](/filings/0001564408-25-000065.md) | [49.7 d](/filings/0001564408-26-000013.md) | [(74.4)](/filings/0001564408-26-000027.md) | [(171)](/filings/0001564408-26-000052.md) | | Interest expense | $m | [5.5](/filings/0001564408-23-000052.md) | [5.3 d](/filings/0001564408-24-000019.md) | [4.7](/filings/0001564408-24-000034.md) | [5.1](/filings/0001564408-25-000052.md) | [5.9](/filings/0001564408-25-000065.md) | [5.8 d](/filings/0001564408-26-000013.md) | [23.4](/filings/0001564408-26-000027.md) | [27.6](/filings/0001564408-26-000052.md) | [34.5](/filings/0001564408-25-000065.md) | [36.5 d](/filings/0001564408-26-000013.md) | [36.8](/filings/0001564408-26-000027.md) | [36.9](/filings/0001564408-26-000052.md) | | Income tax | $m | [5.8](/filings/0001564408-24-000062.md) | [3.3 d](/filings/0001564408-26-000013.md) | [6.9](/filings/0001564408-25-000030.md) | [5.2](/filings/0001564408-25-000052.md) | [8.3](/filings/0001564408-25-000065.md) | [5.2 d](/filings/0001564408-26-000013.md) | [8.4](/filings/0001564408-26-000027.md) | [7.7](/filings/0001564408-26-000052.md) | [0.5](/filings/0001564408-25-000065.md) | [(7.2) d](/filings/0001564408-26-000013.md) | [3.2](/filings/0001564408-26-000027.md) | [2.5](/filings/0001564408-26-000052.md) | | Net income | $m | [(368)](/filings/0001564408-24-000062.md) | [(248) d](/filings/0001564408-26-000013.md) | [(305)](/filings/0001564408-25-000030.md) | [(249)](/filings/0001564408-25-000052.md) | [(153)](/filings/0001564408-25-000065.md) | [9.1 d](/filings/0001564408-26-000013.md) | [(140)](/filings/0001564408-26-000027.md) | [(263)](/filings/0001564408-26-000052.md) | [(104)](/filings/0001564408-25-000065.md) | [45.2 d](/filings/0001564408-26-000013.md) | [(89.0)](/filings/0001564408-26-000027.md) | [(164)](/filings/0001564408-26-000052.md) | | Diluted EPS | $ per share | [(0.23)](/filings/0001564408-24-000062.md) | not reported | [(0.19)](/filings/0001564408-25-000030.md) | [(0.15)](/filings/0001564408-25-000052.md) | [(0.09)](/filings/0001564408-25-000065.md) | not reported | [(0.08)](/filings/0001564408-26-000027.md) | [(0.16)](/filings/0001564408-26-000052.md) | [(0.06)](/filings/0001564408-25-000065.md) | not reported | [(0.05)](/filings/0001564408-26-000027.md) | [(0.10)](/filings/0001564408-26-000052.md) | | Basic EPS | $ per share | [(0.23)](/filings/0001564408-24-000062.md) | not reported | [(0.19)](/filings/0001564408-25-000030.md) | [(0.15)](/filings/0001564408-25-000052.md) | [(0.09)](/filings/0001564408-25-000065.md) | not reported | [(0.08)](/filings/0001564408-26-000027.md) | [(0.16)](/filings/0001564408-26-000052.md) | [(0.06)](/filings/0001564408-25-000065.md) | not reported | [(0.05)](/filings/0001564408-26-000027.md) | [(0.10)](/filings/0001564408-26-000052.md) | - Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfRevenue - Research and development: us-gaap:ResearchAndDevelopmentExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [1,199](/filings/0001564408-23-000052.md) | [1,780](/filings/0001564408-26-000013.md) | [1,060](/filings/0001564408-25-000030.md) | [1,061](/filings/0001564408-25-000052.md) | [965](/filings/0001564408-25-000065.md) | [1,047](/filings/0001564408-26-000013.md) | [911](/filings/0001564408-26-000027.md) | [926](/filings/0001564408-26-000052.md) | [953](/filings/0001564408-25-000065.md) | [1,030](/filings/0001564408-26-000052.md) | [1,062](/filings/0001564408-26-000027.md) | [959](/filings/0001564408-26-000052.md) | | Current assets | $m | [4,874](/filings/0001564408-23-000052.md) | [4,976](/filings/0001564408-25-000019.md) | [4,187](/filings/0001564408-24-000034.md) | [4,421](/filings/0001564408-24-000050.md) | [4,589](/filings/0001564408-24-000062.md) | [4,907](/filings/0001564408-26-000013.md) | [4,577](/filings/0001564408-25-000030.md) | [4,284](/filings/0001564408-25-000052.md) | [4,476](/filings/0001564408-25-000065.md) | [4,585](/filings/0001564408-26-000052.md) | [4,280](/filings/0001564408-26-000027.md) | [4,207](/filings/0001564408-26-000052.md) | | Total assets | $m | [7,723](/filings/0001564408-23-000052.md) | [7,968](/filings/0001564408-25-000019.md) | [7,167](/filings/0001564408-24-000034.md) | [7,420](/filings/0001564408-24-000050.md) | [7,591](/filings/0001564408-24-000062.md) | [7,936](/filings/0001564408-26-000013.md) | [7,589](/filings/0001564408-25-000030.md) | [7,399](/filings/0001564408-25-000052.md) | [7,578](/filings/0001564408-25-000065.md) | [7,678](/filings/0001564408-26-000052.md) | [7,502](/filings/0001564408-26-000027.md) | [7,470](/filings/0001564408-26-000052.md) | | Current liabilities | $m | [1,010](/filings/0001564408-23-000052.md) | [1,134](/filings/0001564408-25-000019.md) | [1,112](/filings/0001564408-24-000034.md) | [1,112](/filings/0001564408-24-000050.md) | [1,136](/filings/0001564408-24-000062.md) | [1,244](/filings/0001564408-26-000013.md) | [1,064](/filings/0001564408-25-000030.md) | [1,103](/filings/0001564408-25-000052.md) | [1,221](/filings/0001564408-25-000065.md) | [1,287](/filings/0001564408-26-000052.md) | [1,214](/filings/0001564408-26-000027.md) | [1,433](/filings/0001564408-26-000052.md) | | Total liabilities | $m | [5,230](/filings/0001564408-23-000052.md) | [5,554](/filings/0001564408-25-000019.md) | [5,036](/filings/0001564408-24-000034.md) | [5,353](/filings/0001564408-24-000050.md) | [5,381](/filings/0001564408-24-000062.md) | [5,486](/filings/0001564408-26-000013.md) | [5,278](/filings/0001564408-25-000030.md) | [5,330](/filings/0001564408-25-000052.md) | [5,351](/filings/0001564408-25-000065.md) | [5,396](/filings/0001564408-26-000052.md) | [5,417](/filings/0001564408-26-000027.md) | [5,543](/filings/0001564408-26-000052.md) | | Long-term debt | $m | [3,748](/filings/0001564408-23-000052.md) | [3,749](/filings/0001564408-25-000019.md) | [3,301](/filings/0001564408-24-000034.md) | [3,639](/filings/0001564408-24-000050.md) | [3,641](/filings/0001564408-24-000062.md) | [3,608](/filings/0001564408-26-000013.md) | [3,577](/filings/0001564408-25-000030.md) | [3,576](/filings/0001564408-25-000052.md) | [3,491](/filings/0001564408-25-000065.md) | [3,490](/filings/0001564408-26-000052.md) | [3,489](/filings/0001564408-26-000027.md) | [3,381](/filings/0001564408-26-000052.md) | | Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | [36.2](/filings/0001564408-26-000013.md) | [36.2](/filings/0001564408-25-000030.md) | [0.0](/filings/0001564408-25-000052.md) | [47.0](/filings/0001564408-25-000065.md) | [47.0](/filings/0001564408-26-000052.md) | [47.0](/filings/0001564408-26-000027.md) | [153](/filings/0001564408-26-000052.md) | | Shareholders' equity | $m | [2,493](/filings/0001564408-24-000062.md) | [2,414](/filings/0001564408-26-000013.md) | [2,131](/filings/0001564408-25-000030.md) | [2,067](/filings/0001564408-25-000052.md) | [2,210](/filings/0001564408-25-000065.md) | [2,451](/filings/0001564408-26-000013.md) | [2,311](/filings/0001564408-26-000027.md) | [2,069](/filings/0001564408-26-000052.md) | [2,227](/filings/0001564408-25-000065.md) | [2,281](/filings/0001564408-26-000052.md) | [2,084](/filings/0001564408-26-000027.md) | [1,927](/filings/0001564408-26-000052.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: us-gaap:LongTermDebt, us-gaap:LongTermDebtNoncurrent - Short-term borrowings: us-gaap:ShortTermBorrowings - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $m | [12.8](/filings/0001564408-24-000062.md) | [165 d](/filings/0001564408-26-000013.md) | [88.4](/filings/0001564408-25-000030.md) | [(21.4)](/filings/0001564408-25-000052.md) | [116](/filings/0001564408-25-000065.md) | [231 d](/filings/0001564408-26-000013.md) | [152](/filings/0001564408-26-000027.md) | [88.5](/filings/0001564408-26-000052.md) | [146](/filings/0001564408-25-000065.md) | [270 d](/filings/0001564408-26-000013.md) | [327](/filings/0001564408-26-000027.md) | [176](/filings/0001564408-26-000052.md) | | Capital expenditure | $m | [73.4](/filings/0001564408-24-000062.md) | [53.7 d](/filings/0001564408-26-000013.md) | [50.4](/filings/0001564408-25-000030.md) | [52.1](/filings/0001564408-25-000052.md) | [44.0](/filings/0001564408-25-000065.md) | [48.3 d](/filings/0001564408-26-000013.md) | [37.2](/filings/0001564408-26-000027.md) | [64.7](/filings/0001564408-26-000052.md) | [53.0](/filings/0001564408-25-000065.md) | [64.0 d](/filings/0001564408-26-000013.md) | [40.8](/filings/0001564408-26-000027.md) | [55.7](/filings/0001564408-26-000052.md) | | Share repurchases | $m | [0.0](/filings/0001564408-24-000062.md) | [189 d](/filings/0001564408-26-000013.md) | [235](/filings/0001564408-25-000030.md) | [76.0](/filings/0001564408-25-000052.md) | [0.0](/filings/0001564408-25-000065.md) | [0.0 d](/filings/0001564408-26-000013.md) | [257](/filings/0001564408-26-000027.md) | [243](/filings/0001564408-26-000052.md) | [0.0](/filings/0001564408-25-000065.md) | [250 d](/filings/0001564408-26-000013.md) | [350](/filings/0001564408-26-000027.md) | [250](/filings/0001564408-26-000052.md) | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock ## Shares | Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | millions of shares | [1,609](/filings/0001564408-23-000052.md) | [1,581](/filings/0001564408-24-000034.md) | [1,603](/filings/0001564408-24-000050.md) | [1,626](/filings/0001564408-24-000062.md) | [1,647](/filings/0001564408-25-000030.md) | [1,645](/filings/0001564408-25-000052.md) | [1,663](/filings/0001564408-25-000065.md) | [1,696](/filings/0001564408-26-000027.md) | [1,675](/filings/0001564408-26-000052.md) | [1,697](/filings/0001564408-25-000065.md) | [1,688](/filings/0001564408-26-000027.md) | [1,663](/filings/0001564408-26-000052.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.